An Act relating to patient choice in dispensing of clinician-administered drugs

This bill (HD 2922) ensures patients have choice when receiving certain outpatient drugs that require clinical administration (like IV treatments), directly affecting patients and healthcare providers. It prohibits health insurance companies from refusing payment, charging extra fees, or penalizing patients when they choose to get these drugs from their preferred provider (e.g., a doctor's office) or pharmacy - not just a plan-selected pharmacy. The law also blocks insurers from steering patients toward specific pharmacies or requiring specialty pharmacies to deliver drugs directly to patients for later administration by a provider. Insurance companies may offer home infusion options but cannot mandate them. This creates a clear standard for coverage without extra costs for patient-selected care.